Special Issue "Recent Progress in Hepatitis E Virus Research"
Deadline for manuscript submissions: closed (30 June 2016).
Interests: hepatitis E virus (HEV) tropism; HEV pathogenesis; acute hepatitis; chronic hepatitis; ribavirin; zoonoses
Special Issues and Collections in MDPI journals
Hepatitis E virus (HEV) was discovered over three decades ago but it remains an enigmatic virus. HEV is hyperendemic in many developing countries where it causes waterborne acute hepatitis that can be severe in pregnant women and patients with underlying chronic liver disease. In developped countries, HEV infection was previously thought to be rare and restricted to travellers returning from developing countries. Thanks to improvements in serologic and molecular tools, the large prevalence of HEV infection in industrialized regions is now recognized. In these areas, HEV is transmitted locally from an animal reservoir and causes acute hepatitis in middle-aged adults and chronic hepatitis in immunocompromised individuals. Extra-hepatic manifestations including neurological and renal manifestations are also increasingly reported. These advances in our understanding of HEV infection were accompanied by major breakthroughs on antiviral drugs and vaccine.
This special issue of Viruses is dedicated to current knowledge on HEV and future directions of research. We hope to assemble a collection of research papers and reviews on HEV life cycle, molecular epidemiology, diagnostic tools, transmission, pathogenesis, treatment and prevention.
Prof. Jacques Izopet
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- HEV life cycle
- HEV genotypes
- anti-HEV antibodies
- HEV RNA
- immune response